Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Phase 2 Trial
Recent news which mentions Phase 2 Trial
< Previous
1
2
3
4
5
6
7
8
9
Next >
Why Are Cortexyme Shares Falling Today?
November 11, 2021
Tickers
CRTX
Tags
Small Cap
Biotech
Alzheimer's disease
From
Benzinga
Freeline Therapeutics Touts Encouraging Data From Fabry Disease Program
November 10, 2021
Tickers
FRLN
Tags
Phase 1 Trial
Biotech
Health Care
From
Benzinga
Finch Therapeutics' C. Difficile Infection Candidate Meets Primary Goal In Mid-Stage Study
November 10, 2021
Tickers
FNCH
Tags
Small Cap
Biotech
Health Care
From
Benzinga
GeoVax Labs In-Licenses Development Rights To Multi-Antigenic COVID-19 Vaccine Candidate
November 10, 2021
Tickers
BNTX
GOVX
PFE
Tags
COVID/19 Vaccine
Briefs
News
From
Benzinga
Immutep's Lead Candidate Data In Breast Cancer Trial Fails To Lift The Stock
November 09, 2021
Tickers
IMMP
Tags
Biotech
Health Care
Market News
From
Benzinga
Compass Pathways' Psilocybin Therapy Shows Mixed Results From Depression Trial
November 09, 2021
Tickers
CMPS
Tags
Small Cap
Biotech
Health Care
From
Benzinga
Seelos Therapeutics To Test Trehalose In Patients With Rare Movement Control Disorder
November 08, 2021
Tickers
SEEL
Tags
SEEL
General
Briefs
From
Benzinga
MorphoSys Presents Early Felzartamab Data From Autoimmune Kidney Disease Trial
November 05, 2021
Tickers
IMAB
MOR
Tags
Trading Ideas
Benzinga
Market News
From
Benzinga
Why Did Calithera Shares Dropped To 52-Week Low In Premarket Friday?
November 05, 2021
Tickers
CALA
Tags
CALA
Short Ideas
Non/Small Cell Lung Cancer
From
Benzinga
Why Did Sangamo Stock Jump 20% Today?
November 04, 2021
Tickers
SGMO
Tags
SGMO
Biotech
Small Cap
From
Benzinga
Novartis' Iptacopan Meets Primary Endpoint Goal In Rare Kidney Disease Trial
November 04, 2021
Tickers
NVS
Tags
Health Care
General
Rare Kidney Diseases
From
Benzinga
Achieve Life Sciences To Start Cytisinicline's Trial For Nicotine E-cigarette Cessation
November 02, 2021
Tickers
ACHV
Tags
Phase 2 Trial
ACHV
Market News
From
Benzinga
Aldeyra's Dry Eye Disease Trial Meets Primary Endpoint, But Did Not Reach Statistical Significance
November 02, 2021
Tickers
ALDX
Tags
Health Care
dry eye disease
Small Cap
From
Benzinga
Galecto To Test GB1211 Combined with Roche's Tecentriq In First Line Lung Cancer Setting
November 02, 2021
Tickers
GLTO
RHHBF
RHHBY
RHHVF
Tags
General
RHHBY
Briefs
From
Benzinga
Metacrine Posts Data From MET409 Combination Trial In Diabetes, NASH Patients
November 02, 2021
Tickers
LLY
MTCR
Tags
Type 2 Diabetes
News
Briefs
From
Benzinga
Cocrystal Pharma Files To Start Human Trial For Protease Inhibitor In COVID-19
November 01, 2021
Tickers
COCP
Tags
Health Care
Phase 1 Trial
Biotech
From
Benzinga
ATAI Life's Schizophrenia Candidate Shows Promising Action In Mid-Stage Study
November 01, 2021
Tickers
ATAI
Tags
Biotech
Health Care
Market News
From
Benzinga
AstraZeneca's Medimmune Terminates DNA Cancer Vaccine Program With Inovio
November 01, 2021
Tickers
AZN
AZNCF
INO
Tags
Benzinga
Phase 2 Trial
AZNCF
From
Benzinga
ARCA Biopharma Stock Gains As Safety Committee Recommends COVID-19 Trial To Continue Unchanged
October 29, 2021
Tickers
ABIO
Tags
COVID/19 Coronavirus
General
why it's moving
From
Benzinga
Inventiva Plans To Start Lanifibranor Combo Study In NASH, Diabetes In 2022
October 28, 2021
Tickers
IVA
LLY
Tags
Type 2 Diabetes
IVA
Briefs
From
Benzinga
Why Did BioVie Shares Jump 21% Today?
October 26, 2021
Tickers
BIVI
Tags
Phase 2 Trial
Parkinson’s Disease
Long Ideas
From
Benzinga
4D Molecular's Fabry Disease Candidate Shows Early Proof-Of-Concept
October 26, 2021
Tickers
FDMT
Tags
General
FDMT
News
From
Benzinga
Ventyx Jumps Over 20% Today After NASDAQ Debut
October 21, 2021
Tickers
BMY
FPX
IPO
IPOS
Tags
IPO
News
Briefs
From
Benzinga
PDS Biotech Pauses Recruitment In PDS0101 Combo Cancer Trial
October 21, 2021
Tickers
MRK
PDSB
Tags
cancer
PDSB
Briefs
From
Benzinga
Stealth Bio Stock Falls On FDA Refusal to File Letter For Barth Syndrome Candidate
October 20, 2021
Tickers
MITO
Tags
Movers
Briefs
News
From
Benzinga
Rocket Pharma Posts Interim Data From Immunodeficiency Disorder Gene Therapy Trial
October 20, 2021
Tickers
RCKT
Tags
General
News
Briefs
From
Benzinga
ImmunityBio Meets Endpoint In Second Indication Cohort In Bladder Cancer Trial
October 19, 2021
Tickers
IBRX
Tags
General
Health Care
Phase 3 Trial
From
Benzinga
Edesa Biotech Shares Gain As Its COVID-19 Antibody Shows Favorable Mortality Reductions
October 19, 2021
Tickers
EDSA
Tags
Biotech
Health Care
Phase 2 Trial
From
Benzinga
InflaRx Secures €44M Grant From German Govt To Advance Its COVID-19 Trial
October 19, 2021
Tickers
IFRX
Tags
Long Ideas
Market News
IFRX
From
Benzinga
Why Are Atea Pharmaceuticals Shares Plunging Today?
October 19, 2021
Tickers
AVIR
RHHBF
RHHBY
RHHVF
Tags
why it's moving
Briefs
News
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.